Skip to main content
Top
Published in: Clinical Rheumatology 12/2017

01-12-2017 | Original Article

Risk association between scleroderma disease characteristics, periodontitis, and tooth loss

Authors: Gaetano Isola, Ray C. Williams, Alberto Lo Gullo, Luca Ramaglia, Marco Matarese, Vincenzo Iorio-Siciliano, Claudio Cosio, Giovanni Matarese

Published in: Clinical Rheumatology | Issue 12/2017

Login to get access

Abstract

Systemic sclerosis (SSc) is a multi-system disorder that can have significant adverse effects on the health of the mouth. The aim of this study was to investigate the associations between the disease characteristics of SSc, periodontal disease (PD), and tooth loss. Fifty-four patients affected by SSc and 55 non-diseased controls were matched for age and gender. SSc was characterized in subtypes and with the mean duration of disease and the Modified Rodnan Skin Score [mRSS]. Patients were surveyed and examined through the evaluation of the periodontal parameters and the number of teeth. A logistic regression analysis showed that patients with SSc presented a higher number of missing teeth (p = 0.001) and a significant median increased odds 2.95 (95% CI 1.26 to 6.84) of PD (defined as clinical attachment loss, CAL) compared to nondiseased controls (6.83, 95% CI 1.94 to 24.36). Moreover, the fewer values of PD was correlated with mRSS in the total SSc group and with the mean duration of disease in patients with limited SSc (p = 0.007), even after adjusting this correlation with the presence of the major organ involvement. This study showed that patients with SSc presented increased odds of PD and tooth loss compared to non-diseased controls. In SSc patients, the magnitude of PD was strongly associated with the mRSS and with the mean duration of the disease. The clinicians should be aware of the potential systemic health problems related to PD.
Literature
1.
go back to reference Derk CT, Jimenez SA (2003) Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2:181–191CrossRefPubMed Derk CT, Jimenez SA (2003) Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2:181–191CrossRefPubMed
2.
go back to reference Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246–2255CrossRefPubMed Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246–2255CrossRefPubMed
3.
go back to reference Amin K, Clarke A, Sivakumar B et al (2011) The psychological impact of facial changes in scleroderma. Psychol Health Med 16:304–312CrossRefPubMed Amin K, Clarke A, Sivakumar B et al (2011) The psychological impact of facial changes in scleroderma. Psychol Health Med 16:304–312CrossRefPubMed
4.
go back to reference Matarese G, Isola G, Alibrandi A et al (2016) Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort. Joint Bone Spine 83:57–62CrossRefPubMed Matarese G, Isola G, Alibrandi A et al (2016) Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort. Joint Bone Spine 83:57–62CrossRefPubMed
5.
go back to reference Albilia JB, Lam DK, Blanas N, Clokie CM, Sándor GK (2007) Small mouths. . . big problems? A review of scleroderma and its oral health implications. J Can Dent Assoc 73:831–836PubMed Albilia JB, Lam DK, Blanas N, Clokie CM, Sándor GK (2007) Small mouths. . . big problems? A review of scleroderma and its oral health implications. J Can Dent Assoc 73:831–836PubMed
6.
go back to reference Baron M, Hudson M, Tatibouet S et al (2014) The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population. Rheumatology 53:1386–1394CrossRefPubMedPubMedCentral Baron M, Hudson M, Tatibouet S et al (2014) The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population. Rheumatology 53:1386–1394CrossRefPubMedPubMedCentral
7.
go back to reference Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997) Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 14:216–248CrossRef Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997) Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 14:216–248CrossRef
8.
go back to reference Matarese G, Isola G, Anastasi GP et al (2012) Immunohistochemical analysis of TGF-β1 and VEGF in gingival and periodontal tissues: a role of these biomarkers in the pathogenesis of scleroderma and periodontal disease. Int J Mol Med 30:502–508CrossRefPubMed Matarese G, Isola G, Anastasi GP et al (2012) Immunohistochemical analysis of TGF-β1 and VEGF in gingival and periodontal tissues: a role of these biomarkers in the pathogenesis of scleroderma and periodontal disease. Int J Mol Med 30:502–508CrossRefPubMed
9.
go back to reference Leung WK, Chu CH, Mok MY, Yeung KW, Ng SK (2011) Periodontal status of adults with systemic sclerosis: Case control study. J Periodontol 82:1140–1145CrossRefPubMed Leung WK, Chu CH, Mok MY, Yeung KW, Ng SK (2011) Periodontal status of adults with systemic sclerosis: Case control study. J Periodontol 82:1140–1145CrossRefPubMed
10.
go back to reference Matarese G, Isola G, Anastasi GP et al (2013) Effects of the Transforming Growth Factor Beta 1 and Vascular Endothelial Growth Factor expressions in the pathogenesis of periodontal disease. Eur J Inflamm 11:479–488CrossRef Matarese G, Isola G, Anastasi GP et al (2013) Effects of the Transforming Growth Factor Beta 1 and Vascular Endothelial Growth Factor expressions in the pathogenesis of periodontal disease. Eur J Inflamm 11:479–488CrossRef
11.
go back to reference Baron M, Hudson M, Dagenais M et al (2016) Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health Study. Arthritis Care Res [Hoboken] 68:673–680CrossRef Baron M, Hudson M, Dagenais M et al (2016) Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health Study. Arthritis Care Res [Hoboken] 68:673–680CrossRef
12.
go back to reference Pischon N, Hoedke D, Kurth S et al (2016) Increased Periodontal Attachment Loss in Patients With Systemic Sclerosis. J Periodontol 87:763–771CrossRefPubMed Pischon N, Hoedke D, Kurth S et al (2016) Increased Periodontal Attachment Loss in Patients With Systemic Sclerosis. J Periodontol 87:763–771CrossRefPubMed
13.
go back to reference Hollan I, Al-Katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD (2007) Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 13:134–137CrossRef Hollan I, Al-Katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD (2007) Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 13:134–137CrossRef
14.
go back to reference Masi AT (1980) Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis [scleroderma]. Arthritis Rheum 23:581–590CrossRef Masi AT (1980) Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis [scleroderma]. Arthritis Rheum 23:581–590CrossRef
15.
go back to reference White B, Bauer EA, Goldsmith LA et al (1995) Guidelines for clinical trials in systemic sclerosis [scleroderma]. I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum 38:351–360CrossRefPubMed White B, Bauer EA, Goldsmith LA et al (1995) Guidelines for clinical trials in systemic sclerosis [scleroderma]. I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum 38:351–360CrossRefPubMed
16.
go back to reference Matarese G, Currò M, Isola G et al (2015) Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages. Amino Acids 47:2447–2455CrossRefPubMed Matarese G, Currò M, Isola G et al (2015) Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages. Amino Acids 47:2447–2455CrossRefPubMed
17.
go back to reference Silness J, Loe H (1964) Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22:121–135CrossRefPubMed Silness J, Loe H (1964) Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22:121–135CrossRefPubMed
18.
go back to reference Furst DE, Clements PJ, Steen VD et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88PubMed Furst DE, Clements PJ, Steen VD et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88PubMed
19.
go back to reference Clements PJ, Furst DE (2003) Systemic Sclerosis, 2nd edn. Lippincott Williams & Wilkins, Los Angeles, pp 129–137 Clements PJ, Furst DE (2003) Systemic Sclerosis, 2nd edn. Lippincott Williams & Wilkins, Los Angeles, pp 129–137
20.
go back to reference Dagenais M, MacDonald D, Baron M et al (2015) The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population. Oral Surg Oral Med Oral Pathol Oral Radiol 120:104–111CrossRefPubMedPubMedCentral Dagenais M, MacDonald D, Baron M et al (2015) The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population. Oral Surg Oral Med Oral Pathol Oral Radiol 120:104–111CrossRefPubMedPubMedCentral
22.
go back to reference Baron M, Hudson M, Tatibouet S et al (2015) Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III. Arthritis Care Res [Hoboken] 67:681–690CrossRef Baron M, Hudson M, Tatibouet S et al (2015) Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III. Arthritis Care Res [Hoboken] 67:681–690CrossRef
23.
go back to reference White SC, Frey NW, Blaschke DD et al (1977) Oral radiographic changes in patients with progressive systemic sclerosis [scleroderma]. J Am Dent Assoc 46:178–182 White SC, Frey NW, Blaschke DD et al (1977) Oral radiographic changes in patients with progressive systemic sclerosis [scleroderma]. J Am Dent Assoc 46:178–182
24.
go back to reference Isola G, Matarese G, Cordasco G, Rotondo F, Crupi A, Ramaglia L (2015) Anticoagulant therapy in patients undergoing dental interventions: a critical review of the literature and current perspectives. Minerva Stomatol 64:21–46PubMed Isola G, Matarese G, Cordasco G, Rotondo F, Crupi A, Ramaglia L (2015) Anticoagulant therapy in patients undergoing dental interventions: a critical review of the literature and current perspectives. Minerva Stomatol 64:21–46PubMed
25.
go back to reference Bender P, Bürgin WB, Sculean A, Eick S (2017) Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis - a systematic review and meta-analysis. Clin Oral Investig 21:33–42CrossRefPubMed Bender P, Bürgin WB, Sculean A, Eick S (2017) Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis - a systematic review and meta-analysis. Clin Oral Investig 21:33–42CrossRefPubMed
26.
go back to reference Laugisch O, Wong A, Sroka A et al (2016) Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis. Clin Oral Investig 20:675–683CrossRefPubMed Laugisch O, Wong A, Sroka A et al (2016) Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis. Clin Oral Investig 20:675–683CrossRefPubMed
28.
go back to reference Scardina GA, Pizzigatti ME, Messina P (2005) Periodontal microcirculatory abnormalities in patients with systemic sclerosis. J Periodontol 76:1991–1995CrossRefPubMed Scardina GA, Pizzigatti ME, Messina P (2005) Periodontal microcirculatory abnormalities in patients with systemic sclerosis. J Periodontol 76:1991–1995CrossRefPubMed
29.
go back to reference Ozcelik O, Haytac MC, Ergin M, Antmen B, Seydaoglu G (2008) The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: Their possible effects on gingival inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:481–485CrossRefPubMed Ozcelik O, Haytac MC, Ergin M, Antmen B, Seydaoglu G (2008) The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: Their possible effects on gingival inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:481–485CrossRefPubMed
30.
go back to reference Calderaro DC, Ferreira GA, Corrêa JD et al (2017) Is chronic periodontitis premature in systemic lupus erythematosus patients? Clin Rheumatol 36:713–718CrossRefPubMed Calderaro DC, Ferreira GA, Corrêa JD et al (2017) Is chronic periodontitis premature in systemic lupus erythematosus patients? Clin Rheumatol 36:713–718CrossRefPubMed
31.
go back to reference Lo Giudice G, Lo Giudice R, Matarese G et al (2015) Evaluation of magnification systems in restorative dentistry. An in-vitro study. Dent Cadmos 83:296–305CrossRef Lo Giudice G, Lo Giudice R, Matarese G et al (2015) Evaluation of magnification systems in restorative dentistry. An in-vitro study. Dent Cadmos 83:296–305CrossRef
32.
go back to reference Pugliese C, van der Vinne RT, Campos LM et al (2016) Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease? Clin Rheumatol 35:81–91CrossRefPubMed Pugliese C, van der Vinne RT, Campos LM et al (2016) Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease? Clin Rheumatol 35:81–91CrossRefPubMed
33.
go back to reference Becker MO, Riemekasten G (2016) Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course. Expert Rev Clin Immunol 12:115–135CrossRefPubMed Becker MO, Riemekasten G (2016) Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course. Expert Rev Clin Immunol 12:115–135CrossRefPubMed
34.
go back to reference Cavuoti S, Matarese G, Isola G, Abdolreza J, Femiano F, Perillo L (2016) Combined orthodontic-surgical management of a transmigrated mandibular canine: a case report. Angle Orthod 86:681–691CrossRefPubMed Cavuoti S, Matarese G, Isola G, Abdolreza J, Femiano F, Perillo L (2016) Combined orthodontic-surgical management of a transmigrated mandibular canine: a case report. Angle Orthod 86:681–691CrossRefPubMed
35.
go back to reference Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr (2011) Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 70:104–109CrossRefPubMed Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr (2011) Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 70:104–109CrossRefPubMed
36.
go back to reference Arana-Ruiz JC, Silveira LH, Castillo-Martínez D, Amezcua-Guerra LM (2016) Assessment of nailfold capillaries with a handheld dermatoscope may discriminate the extent of organ involvement in patients with systemic sclerosis. Clin Rheumatol 35:479–482CrossRefPubMed Arana-Ruiz JC, Silveira LH, Castillo-Martínez D, Amezcua-Guerra LM (2016) Assessment of nailfold capillaries with a handheld dermatoscope may discriminate the extent of organ involvement in patients with systemic sclerosis. Clin Rheumatol 35:479–482CrossRefPubMed
37.
go back to reference Matarese G, Isola G, Anastasi GP et al (2017) Immunohistochemical analysis of TGF-β1 and VEGF in gingival and periodontal tissues: a role of these biomarkers in the pathogenesis of scleroderma and periodontal disease. Int J Mol Med 30:502–8. https:/doi.org/10.3892/ijmm.2012.1024 Matarese G, Isola G, Anastasi GP et al (2017) Immunohistochemical analysis of TGF-β1 and VEGF in gingival and periodontal tissues: a role of these biomarkers in the pathogenesis of scleroderma and periodontal disease. Int J Mol Med 30:502–8. https:​/​doi.​org/​10.​3892/​ijmm.​2012.​1024
38.
go back to reference Tzach-Nahman R, Nashef R, Fleissig O, Palmon A, Shapira L, Wilensky A, Nussbaum G (2017) Oral fibroblasts modulate the macrophage response to bacterial challenge. Scientific Reports 7:11516 Tzach-Nahman R, Nashef R, Fleissig O, Palmon A, Shapira L, Wilensky A, Nussbaum G (2017) Oral fibroblasts modulate the macrophage response to bacterial challenge. Scientific Reports 7:11516
Metadata
Title
Risk association between scleroderma disease characteristics, periodontitis, and tooth loss
Authors
Gaetano Isola
Ray C. Williams
Alberto Lo Gullo
Luca Ramaglia
Marco Matarese
Vincenzo Iorio-Siciliano
Claudio Cosio
Giovanni Matarese
Publication date
01-12-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3861-9

Other articles of this Issue 12/2017

Clinical Rheumatology 12/2017 Go to the issue